GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shire PLC (NAS:SHPG) » Definitions » 3-Year Dividend Growth Rate

Shire (SHPG) 3-Year Dividend Growth Rate : 0.00% (As of Sep. 2018)


View and export this data going back to 1998. Start your Free Trial

What is Shire 3-Year Dividend Growth Rate?

Shire's Dividends per Share for the three months ended in Sep. 2018 was $0.17.

The historical rank and industry rank for Shire's 3-Year Dividend Growth Rate or its related term are showing as below:

SHPG's 3-Year Dividend Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 14.5
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Shire's Dividend Payout Ratio for the three months ended in Sep. 2018 was 0.10. As of today, Shire's Dividend Yield % is 0.59%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Shire's 3-Year Dividend Growth Rate

For the Biotechnology subindustry, Shire's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shire's 3-Year Dividend Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shire's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Shire's 3-Year Dividend Growth Rate falls into.



Shire 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Shire  (NAS:SHPG) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Shire's Dividend Payout Ratio for the quarter that ended in Sep. 2018 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Sep. 2018 )/ EPS without NRI (Q: Sep. 2018 )
=0.168/ 1.74
=0.10

During the past 13 years, the highest Dividend Payout Ratio of Shire was 0.07. The lowest was 0.00. And the median was 0.00.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

During the past 13 years, the highest Dividend Yield of Shire was 0.59%. The lowest was 0.00%. And the median was 0.00%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shire 3-Year Dividend Growth Rate Related Terms>


Shire (SHPG) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Shire is a diversified, Ireland-based specialty drug firm. Shire has grown primarily through mergers and acquisitions, including the Transkaryotic Therapies acquisition in 2005, which established its genetic disease business with Replagal and Elaprase, and the merger with New River in 2007, which brought full rights to neuroscience drug Vyvanse. Shire completed the acquisition of ViroPharma (genetic diseases) in 2014, NPS Pharma (internal medicine) in 2015, and Baxalta (hematology, immunology, and oncology) and Dyax (genetic diseases) in 2016.
Executives
James H Cavanaugh director 265 HOTHORPE LANE, VILLANOVA PA 19085

Shire (SHPG) Headlines

From GuruFocus

Shire Completes Sale of Oncology Franchise

By Marketwired Marketwired 08-31-2018